首页 > 最新文献

Canadian Journal of Anesthesia-Journal Canadien D Anesthesie最新文献

英文 中文
Dr. Harold Griffith and Sir Robert Macintosh: a British response to curare's introduction to anesthesia. 哈罗德·格里菲斯博士和罗伯特·麦金托什爵士:英国人对柯拉尔引入麻醉的反应。
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-03-19 DOI: 10.1007/s12630-026-03079-6
Reda Hessi, Noha Elsherbini, Mary Hague-Yearl, Steven B Backman

Curare's implementation into anesthesia care by Dr. Harold Griffith was facilitated by the availability of medical-grade curare, the demonstration that it could provide safe muscle relaxation in psychiatric patients undergoing "shock therapy," and the foresight of a Squibb scientist who realized its potential in the operating room. Griffith's demonstration that curare safely provided muscle relaxation in surgical patients eliminated the need for dangerously high doses of anesthetic gases. This helped pave the way to "balanced anesthesia," whereby small doses of selectively acting drugs are given to achieve specific ends.Curare's initial reception by anesthesiologists, particularly in the UK, was frosty owing to its lingering reputation as a lethal poison associated with witchcraft. We recently unearthed a scathing review of Griffith's work housed in the Wellcome Collection (London, UK). That review, requested by Sir Robert Macintosh, Oxford University's inaugural Nuffield Professor of Anesthesia, was authored by his colleague, Dr. Stuart L. Cowan. In hindsight, this disparaging assessment is especially fascinating: Why was this review so negative when curare would have such a remarkable positive impact on medicine? In the present Special Article, we present the above British response to curare's introduction to anesthesia and trace curare's remarkable journey through the contributions of explorers, scientists, and clinicians preceding the review to help put it in perspective.

哈罗德·格里菲斯(Harold Griffith)博士将Curare应用于麻醉护理,这得益于医疗级Curare的可用性,证明它可以为接受“休克疗法”的精神病患者提供安全的肌肉放松,以及一位施奎布(Squibb)科学家的远见卓识,他意识到它在手术室中的潜力。格里菲斯的论证表明,curare可以安全地为外科病人提供肌肉放松,从而消除了对危险的高剂量麻醉气体的需要。这为“平衡麻醉”铺平了道路,通过小剂量的选择性作用药物来达到特定的目的。麻醉师,尤其是英国麻醉师最初对Curare的反应冷淡,因为它一直被认为是一种与巫术有关的致命毒药。我们最近在英国伦敦的惠康收藏馆(Wellcome Collection)发现了一篇对格里菲斯作品的尖锐评论。牛津大学首任纳菲尔德麻醉学教授罗伯特·麦金托什爵士(Sir Robert Macintosh)要求进行这项审查,由他的同事斯图尔特·l·考恩(Stuart L. Cowan)博士撰写。事后看来,这种贬低性的评价特别吸引人:为什么当curare对医学产生如此显著的积极影响时,这篇评论却如此消极?在这篇特别文章中,我们将介绍上述英国人对curare引入麻醉的回应,并通过回顾之前探索者、科学家和临床医生的贡献来追溯curare的非凡历程,以帮助人们正确看待它。
{"title":"Dr. Harold Griffith and Sir Robert Macintosh: a British response to curare's introduction to anesthesia.","authors":"Reda Hessi, Noha Elsherbini, Mary Hague-Yearl, Steven B Backman","doi":"10.1007/s12630-026-03079-6","DOIUrl":"https://doi.org/10.1007/s12630-026-03079-6","url":null,"abstract":"<p><p>Curare's implementation into anesthesia care by Dr. Harold Griffith was facilitated by the availability of medical-grade curare, the demonstration that it could provide safe muscle relaxation in psychiatric patients undergoing \"shock therapy,\" and the foresight of a Squibb scientist who realized its potential in the operating room. Griffith's demonstration that curare safely provided muscle relaxation in surgical patients eliminated the need for dangerously high doses of anesthetic gases. This helped pave the way to \"balanced anesthesia,\" whereby small doses of selectively acting drugs are given to achieve specific ends.Curare's initial reception by anesthesiologists, particularly in the UK, was frosty owing to its lingering reputation as a lethal poison associated with witchcraft. We recently unearthed a scathing review of Griffith's work housed in the Wellcome Collection (London, UK). That review, requested by Sir Robert Macintosh, Oxford University's inaugural Nuffield Professor of Anesthesia, was authored by his colleague, Dr. Stuart L. Cowan. In hindsight, this disparaging assessment is especially fascinating: Why was this review so negative when curare would have such a remarkable positive impact on medicine? In the present Special Article, we present the above British response to curare's introduction to anesthesia and trace curare's remarkable journey through the contributions of explorers, scientists, and clinicians preceding the review to help put it in perspective.</p>","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147488692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound examination of gastric contents in patients undergoingambulatory surgery. 门诊手术患者胃内容物的超声检查。
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-03-17 DOI: 10.1007/s12630-026-03082-x
Olivier Choquet, Fabien Swisser, Romain Delannoy, Philippe Biboulet, Corentin Simon, Sophie Bringuier, Xavier Capdevila
{"title":"Ultrasound examination of gastric contents in patients undergoingambulatory surgery.","authors":"Olivier Choquet, Fabien Swisser, Romain Delannoy, Philippe Biboulet, Corentin Simon, Sophie Bringuier, Xavier Capdevila","doi":"10.1007/s12630-026-03082-x","DOIUrl":"https://doi.org/10.1007/s12630-026-03082-x","url":null,"abstract":"","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence and characteristics of imposter syndrome among anesthesiology staff and trainees in British Columbia, Canada: an online survey study. 加拿大不列颠哥伦比亚省麻醉学工作人员和培训生冒名顶替综合症的患病率和特征:一项在线调查研究。
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-03-17 DOI: 10.1007/s12630-026-03083-w
Nancy Wang, Nicholas C West, McKenna Postles, Lynnie R Correll
{"title":"The prevalence and characteristics of imposter syndrome among anesthesiology staff and trainees in British Columbia, Canada: an online survey study.","authors":"Nancy Wang, Nicholas C West, McKenna Postles, Lynnie R Correll","doi":"10.1007/s12630-026-03083-w","DOIUrl":"https://doi.org/10.1007/s12630-026-03083-w","url":null,"abstract":"","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Local anesthetic dosing for fascial plane blocks to avoid systemic toxicity: a narrative review. 更正:局部麻醉剂量的筋膜平面阻滞,以避免全身毒性:叙述性回顾。
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-03-17 DOI: 10.1007/s12630-026-03076-9
Jonathan G Bailey, Garrett Barry, Thomas Volk
{"title":"Correction: Local anesthetic dosing for fascial plane blocks to avoid systemic toxicity: a narrative review.","authors":"Jonathan G Bailey, Garrett Barry, Thomas Volk","doi":"10.1007/s12630-026-03076-9","DOIUrl":"https://doi.org/10.1007/s12630-026-03076-9","url":null,"abstract":"","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147476187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Special announcement: Guidelines to the Practice of Anesthesia-Revised Edition 2026. 特别公告:麻醉实践指南-修订版2026。
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-03-12 DOI: 10.1007/s12630-026-03080-z
Gregory R Dobson, Anthony Chau
{"title":"Special announcement: Guidelines to the Practice of Anesthesia-Revised Edition 2026.","authors":"Gregory R Dobson, Anthony Chau","doi":"10.1007/s12630-026-03080-z","DOIUrl":"https://doi.org/10.1007/s12630-026-03080-z","url":null,"abstract":"","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidelines to the Practice of Anesthesia-Revised Edition 2026. 麻醉实践指南-修订版2026。
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-03-12 DOI: 10.1007/s12630-026-03075-w
Gregory R Dobson, Alex Beomju Bak, Anthony Chau, Justine Denomme, Giuseppe Fuda, Conor Mc Donnell, Robert Milkovich, Andrew D Milne, John Murdoch, Kathryn Sparrow, Yamini Subramani, Christopher Young

Overview: The Guidelines to the Practice of Anesthesia-Revised Edition 2026 (the Guidelines) were prepared by the Canadian Anesthesiologists' Society (CAS), which reserves the right to determine the publication and distribution of the Guidelines. The Guidelines are subject to revision and updated versions are published annually. The Guidelines supersede all previously published versions of this document. Although the CAS encourages Canadian anesthesiologists to adhere to its practice guidelines to ensure high-quality patient care, the CAS cannot guarantee any specific patient outcome. Anesthesiologists should exercise their own professional judgement in determining the proper course of action for any patient's circumstances. The CAS assumes no responsibility or liability for any error or omission arising from the use of any information contained in its Guidelines to the Practice of Anesthesia.

概述:《麻醉实践指南- 2026修订版》(以下简称《指南》)由加拿大麻醉师协会(CAS)编制,该协会保留决定指南出版和分发的权利。《指引》不时修订,并每年出版最新版本。该指南取代本文件以前发布的所有版本。尽管CAS鼓励加拿大麻醉师遵守其实践指南,以确保高质量的患者护理,但CAS不能保证任何特定的患者结果。麻醉师应该运用自己的专业判断,根据病人的情况决定适当的治疗方案。对于因使用麻醉实践指南中包含的任何信息而产生的任何错误或遗漏,CAS不承担任何责任或责任。
{"title":"Guidelines to the Practice of Anesthesia-Revised Edition 2026.","authors":"Gregory R Dobson, Alex Beomju Bak, Anthony Chau, Justine Denomme, Giuseppe Fuda, Conor Mc Donnell, Robert Milkovich, Andrew D Milne, John Murdoch, Kathryn Sparrow, Yamini Subramani, Christopher Young","doi":"10.1007/s12630-026-03075-w","DOIUrl":"https://doi.org/10.1007/s12630-026-03075-w","url":null,"abstract":"<p><strong>Overview: </strong>The Guidelines to the Practice of Anesthesia-Revised Edition 2026 (the Guidelines) were prepared by the Canadian Anesthesiologists' Society (CAS), which reserves the right to determine the publication and distribution of the Guidelines. The Guidelines are subject to revision and updated versions are published annually. The Guidelines supersede all previously published versions of this document. Although the CAS encourages Canadian anesthesiologists to adhere to its practice guidelines to ensure high-quality patient care, the CAS cannot guarantee any specific patient outcome. Anesthesiologists should exercise their own professional judgement in determining the proper course of action for any patient's circumstances. The CAS assumes no responsibility or liability for any error or omission arising from the use of any information contained in its Guidelines to the Practice of Anesthesia.</p>","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuraxial anesthesia in patients with placenta accreta spectrum disorder: balancing clinical strategy with shared decision-making. 增生性胎盘谱系障碍患者的轴向麻醉:平衡临床策略与共同决策。
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-03-09 DOI: 10.1007/s12630-026-03078-7
Valerie Zaphiratos, Ronald B George
{"title":"Neuraxial anesthesia in patients with placenta accreta spectrum disorder: balancing clinical strategy with shared decision-making.","authors":"Valerie Zaphiratos, Ronald B George","doi":"10.1007/s12630-026-03078-7","DOIUrl":"https://doi.org/10.1007/s12630-026-03078-7","url":null,"abstract":"","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147391477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of therapeutic interventions combined with lung-protective ventilation on long-term mortality of patients with acute respiratory distress syndrome: a network meta-analysis. 治疗干预联合肺保护性通气对急性呼吸窘迫综合征患者长期死亡率的影响:一项网络荟萃分析
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-03-04 DOI: 10.1007/s12630-026-03069-8
Hiroko Aoyama, Kanji Uchida, Kazuyoshi Aoyama, Alan Yang, Petros Pechlivanoglou, Marina Englesakis, Yoshitsugu Yamada, Eddy Fan

Purpose: Long-term effects of ventilatory strategies/adjunctive therapies received in the intensive care unit on mortality of patients with acute respiratory distress syndrome (ARDS) is uncertain. To explore 180-day mortality in adult patients with ARDS, we conducted a network meta-analysis (NMA) comparing the effects of various prespecified interventions added to lung-protective ventilation (LPV).

Source: We systematically searched six databases on 8 November 2024. Two reviewers independently identified eligible randomized clinical trials with published Kaplan-Meier curves, exploring prespecified interventions combined with LPV and LPV alone. Data were synthesized with NMA of survival curves using Bayesian random effects fractional polynomial models.

Principal findings: Twenty-two trials with 8,653 participants assessed six different interventions added to LPV (open lung strategy, neuromuscular blockade [NMBA], corticosteroids, high-frequency oscillatory ventilation [HFOV], prone positioning, and venovenous extracorporeal membrane oxygenation [VV ECMO]), compared with LPV alone. We did not include inhaled pulmonary vasodilator trials. The primary NMA computed survival probability of each intervention on the basis of survival probability of LPV alone at 180 days (0.52; 95% credible interval, 0.49 to 0.55). Compared with LPV alone, 1) the evidence suggests prone positioning results in a reduction in 180-day mortality; 2) an open lung strategy does not reduce 180-day mortality; 3) VV ECMO, NMBA, and corticosteroids may reduce 180-day mortality (very uncertain); and 4) HFOV may increase 180-day mortality (very uncertain). We extrapolated reported mortalities to 180-day mortality in 16 trials, where there might be discrepancy between raw and extrapolated numbers in event rate.

Conclusions: Prone positioning may improve long-term mortality in patients with ARDS.

Study registration: PROSPERO ( CRD42019131849 ); first submitted 26 April 2019.

目的:重症监护病房接受的通气策略/辅助治疗对急性呼吸窘迫综合征(ARDS)患者死亡率的长期影响尚不确定。为了探讨成年ARDS患者180天的死亡率,我们进行了一项网络荟萃分析(NMA),比较了各种预先指定的干预措施对肺保护性通气(LPV)的影响。资料来源:我们在2024年11月8日系统地检索了6个数据库。两位审稿人独立确定了符合条件的随机临床试验,并发表了Kaplan-Meier曲线,探索预先指定的干预措施联合LPV和单独LPV。采用贝叶斯随机效应分数多项式模型对生存曲线进行NMA综合。主要发现:与单独LPV相比,22项涉及8,653名参与者的试验评估了加入LPV的六种不同干预措施(开放肺策略、神经肌肉阻断[NMBA]、皮质类固醇、高频振荡通气[HFOV]、俯卧位和静脉-静脉体外膜氧合[VV ECMO])。我们没有纳入吸入肺血管扩张剂试验。初级NMA以LPV单独在180天的生存概率为基础计算每次干预的生存概率(0.52;95%可信区间为0.49 ~ 0.55)。与单独俯卧位相比,1)有证据表明俯卧位可降低180天死亡率;2)开放肺策略不能降低180天死亡率;3) VV ECMO、NMBA和皮质类固醇可降低180天死亡率(非常不确定);4) HFOV可能增加180天死亡率(非常不确定)。我们在16项试验中将报告的死亡率外推为180天死亡率,其中原始数据和外推数据在事件发生率方面可能存在差异。结论:俯卧位可改善ARDS患者的长期死亡率。研究注册:PROSPERO (CRD42019131849);首次提交于2019年4月26日。
{"title":"Effect of therapeutic interventions combined with lung-protective ventilation on long-term mortality of patients with acute respiratory distress syndrome: a network meta-analysis.","authors":"Hiroko Aoyama, Kanji Uchida, Kazuyoshi Aoyama, Alan Yang, Petros Pechlivanoglou, Marina Englesakis, Yoshitsugu Yamada, Eddy Fan","doi":"10.1007/s12630-026-03069-8","DOIUrl":"https://doi.org/10.1007/s12630-026-03069-8","url":null,"abstract":"<p><strong>Purpose: </strong>Long-term effects of ventilatory strategies/adjunctive therapies received in the intensive care unit on mortality of patients with acute respiratory distress syndrome (ARDS) is uncertain. To explore 180-day mortality in adult patients with ARDS, we conducted a network meta-analysis (NMA) comparing the effects of various prespecified interventions added to lung-protective ventilation (LPV).</p><p><strong>Source: </strong>We systematically searched six databases on 8 November 2024. Two reviewers independently identified eligible randomized clinical trials with published Kaplan-Meier curves, exploring prespecified interventions combined with LPV and LPV alone. Data were synthesized with NMA of survival curves using Bayesian random effects fractional polynomial models.</p><p><strong>Principal findings: </strong>Twenty-two trials with 8,653 participants assessed six different interventions added to LPV (open lung strategy, neuromuscular blockade [NMBA], corticosteroids, high-frequency oscillatory ventilation [HFOV], prone positioning, and venovenous extracorporeal membrane oxygenation [VV ECMO]), compared with LPV alone. We did not include inhaled pulmonary vasodilator trials. The primary NMA computed survival probability of each intervention on the basis of survival probability of LPV alone at 180 days (0.52; 95% credible interval, 0.49 to 0.55). Compared with LPV alone, 1) the evidence suggests prone positioning results in a reduction in 180-day mortality; 2) an open lung strategy does not reduce 180-day mortality; 3) VV ECMO, NMBA, and corticosteroids may reduce 180-day mortality (very uncertain); and 4) HFOV may increase 180-day mortality (very uncertain). We extrapolated reported mortalities to 180-day mortality in 16 trials, where there might be discrepancy between raw and extrapolated numbers in event rate.</p><p><strong>Conclusions: </strong>Prone positioning may improve long-term mortality in patients with ARDS.</p><p><strong>Study registration: </strong>PROSPERO ( CRD42019131849 ); first submitted 26 April 2019.</p>","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147357760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
More than meets the "I": the complex decision to withhold or continue renin-angiotensin-aldosterone system inhibitors before surgery. 比满足“我”:复杂的决定保留或继续术前肾素-血管紧张素-醛固酮系统抑制剂。
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-02-25 DOI: 10.1007/s12630-026-03074-x
Michael A Smith
{"title":"More than meets the \"I\": the complex decision to withhold or continue renin-angiotensin-aldosterone system inhibitors before surgery.","authors":"Michael A Smith","doi":"10.1007/s12630-026-03074-x","DOIUrl":"https://doi.org/10.1007/s12630-026-03074-x","url":null,"abstract":"","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147285901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe maternal morbidity following Cesarean hysterectomy for placenta accreta spectrum: a historical cohort study. 重度产妇发病率剖宫产子宫切除术后的胎盘增生谱:一项历史队列研究。
IF 3.3 3区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-02-18 DOI: 10.1007/s12630-026-03068-9
Alexandra Bickett, Matthew Fuller, Jennifer B Gilner, Luke A Gatta, Vijay Krishnamorthy, Tetsu Ohnuma, Karthik Raghunathan, Ashraf S Habib

Purpose: We sought to evaluate the incidence of severe maternal morbidity (SMM) and intensive care unit (ICU) admissions following Cesarean hysterectomy for placenta accreta spectrum (PAS) and to assess factors associated with those outcomes.

Methods: We conducted a historical cohort study to identify patients with PAS who had Cesarean hysterectomy in the USA using delivery hospitalizations in the Premier Inc. database (Charlotte, NC, USA) from 1 October 2015 to 30 June 2021. We collected information about the 21 SMM events as defined by the Centers for Disease Control and Prevention. Since hysterectomy is one of those SMM events, and all patients in our cohort underwent hysterectomy, we assessed SMM events, excluding hysterectomy, using International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) diagnosis codes. We performed mixed-effects logistic regression models with random intercepts for hospitals to assess for factors associated with SMM.

Results: Among 1,972 patients, SMM (excluding hysterectomy) and ICU admission occurred in 54% and 44% of the patients, respectively. The following factors were associated with SMM: placenta percreta compared with accreta (odds ratio [OR], 1.46; 95% confidence interval [CI], 1.09 to 1.95), blood loss anemia (OR, 1.71; 95% CI, 1.26 to 2.33), deficiency anemia (OR, 0.64; 95% CI, 0.43 to 0.96), neuraxial compared with general anesthesia (OR, 0.64; 95% CI, 0.44 to 0.91), admission year (OR, 0.73; 95% CI, 0.68 to 0.80), and hospitals in the Midwest (OR, 0.56, 95% CI, 0.33 to 0.96) and West (OR, 0.47, 95% CI, 0.26 to 0.84) regions of the USA compared with those in the South.

Conclusions: Patients with PAS who underwent Cesarean hysterectomy had a high incidence of SMM and ICU admissions. This finding highlights the need for all centres performing Cesarean deliveries to have plans in place to manage patients with PAS.

目的:我们试图评估严重产妇发病率(SMM)和重症监护病房(ICU)入院后剖宫产子宫切除术的胎盘增生谱(PAS),并评估与这些结果相关的因素。方法:我们进行了一项历史队列研究,以确定2015年10月1日至2021年6月30日期间在Premier Inc.数据库(Charlotte, NC, USA)使用分娩住院治疗的美国剖宫产子宫切除术的PAS患者。我们收集了疾病控制和预防中心定义的21例SMM事件的信息。由于子宫切除术是这些SMM事件之一,并且我们队列中的所有患者都进行了子宫切除术,我们使用国际疾病和相关健康问题统计分类第10版(ICD-10)诊断代码评估SMM事件,不包括子宫切除术。我们对医院采用随机截距的混合效应逻辑回归模型来评估与SMM相关的因素。结果:1972例患者中,SMM(不包括子宫切除术)和ICU的发生率分别为54%和44%。以下因素与SMM相关:胎盘植入与胎盘植入(优势比[OR], 1.46; 95%可信区间[CI], 1.09 ~ 1.95)、失血性贫血(优势比[OR], 1.71; 95% CI, 1.26 ~ 2.33)、缺乏性贫血(优势比,0.64;95% CI, 0.43 ~ 0.96)、神经性贫血与全身麻醉(优势比,0.64;95% CI, 0.44 ~ 0.91)、住院年份(优势比,0.73;95% CI, 0.68至0.80),以及美国中西部地区(OR, 0.56, 95% CI, 0.33至0.96)和西部地区(OR, 0.47, 95% CI, 0.26至0.84)的医院与南部地区的医院相比。结论:接受剖宫产子宫切除术的PAS患者SMM和ICU住院的发生率较高。这一发现强调了所有进行剖宫产的中心都需要有适当的计划来管理PAS患者。
{"title":"Severe maternal morbidity following Cesarean hysterectomy for placenta accreta spectrum: a historical cohort study.","authors":"Alexandra Bickett, Matthew Fuller, Jennifer B Gilner, Luke A Gatta, Vijay Krishnamorthy, Tetsu Ohnuma, Karthik Raghunathan, Ashraf S Habib","doi":"10.1007/s12630-026-03068-9","DOIUrl":"https://doi.org/10.1007/s12630-026-03068-9","url":null,"abstract":"<p><strong>Purpose: </strong>We sought to evaluate the incidence of severe maternal morbidity (SMM) and intensive care unit (ICU) admissions following Cesarean hysterectomy for placenta accreta spectrum (PAS) and to assess factors associated with those outcomes.</p><p><strong>Methods: </strong>We conducted a historical cohort study to identify patients with PAS who had Cesarean hysterectomy in the USA using delivery hospitalizations in the Premier Inc. database (Charlotte, NC, USA) from 1 October 2015 to 30 June 2021. We collected information about the 21 SMM events as defined by the Centers for Disease Control and Prevention. Since hysterectomy is one of those SMM events, and all patients in our cohort underwent hysterectomy, we assessed SMM events, excluding hysterectomy, using International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) diagnosis codes. We performed mixed-effects logistic regression models with random intercepts for hospitals to assess for factors associated with SMM.</p><p><strong>Results: </strong>Among 1,972 patients, SMM (excluding hysterectomy) and ICU admission occurred in 54% and 44% of the patients, respectively. The following factors were associated with SMM: placenta percreta compared with accreta (odds ratio [OR], 1.46; 95% confidence interval [CI], 1.09 to 1.95), blood loss anemia (OR, 1.71; 95% CI, 1.26 to 2.33), deficiency anemia (OR, 0.64; 95% CI, 0.43 to 0.96), neuraxial compared with general anesthesia (OR, 0.64; 95% CI, 0.44 to 0.91), admission year (OR, 0.73; 95% CI, 0.68 to 0.80), and hospitals in the Midwest (OR, 0.56, 95% CI, 0.33 to 0.96) and West (OR, 0.47, 95% CI, 0.26 to 0.84) regions of the USA compared with those in the South.</p><p><strong>Conclusions: </strong>Patients with PAS who underwent Cesarean hysterectomy had a high incidence of SMM and ICU admissions. This finding highlights the need for all centres performing Cesarean deliveries to have plans in place to manage patients with PAS.</p>","PeriodicalId":56145,"journal":{"name":"Canadian Journal of Anesthesia-Journal Canadien D Anesthesie","volume":" ","pages":""},"PeriodicalIF":3.3,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146222262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Canadian Journal of Anesthesia-Journal Canadien D Anesthesie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1